Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 18 to 67 of 3228 in total 
    Value Type: Measured
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
892.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-4 subunit. [source:swissprot;acc:p50150]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.134\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04922\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-3 subunit. [source:swissprot;acc:p29798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-8 subunit (gamma-9). [source:swissprot;acc:q9uk08]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.507\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 subunit. [source:swissprot;acc:p30670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.633\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04837\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.697\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.893\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04793\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1835.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
896.972\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.71\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
907.546\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02382\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
907.564\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02378\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.76\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
907.741\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02344\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
907.763\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02339\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
907.774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1836.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
907.903\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
907.978\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.02297\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1857.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
958.237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.93827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1881.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1027.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.83093\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 1 (transducin beta chain 1). [source:swissprot;acc:p04901]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1931.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1057.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 4 (transducin beta chain 4). [source:swissprot;acc:q9hav0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1926.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1056.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82448\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
51\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
52\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase dna binding protein 5. [source:refseq;acc:nm\_015557]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
53\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
54\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex 2. [source:refseq;acc:nm\_020892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1618.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2651.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63814\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
55\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1629.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2662.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-lak cell-originated protein kinase; spermatogenesis-related protein kinase; pdz-binding kinase; pbk; mapkk-like protein kinase; serine/threonine protein kinase. [source:refseq;acc:nm\_018492]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
57\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 3; sam68-like phosphotyrosine protein, t-star. [source:refseq;acc:nm\_006558]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 1; gap-associated tyrosine phosphoprotein p62 (sam68). [source:refseq;acc:nm\_006559]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
61\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
62\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/